Data Driven Methods for Kinase Drug Design

webinar

Thu, 27 Apr 2023, 16:00 CEST (Berlin)

Prof. Dr. Andrea Volkamer, Saarland University, Germany

Data Driven Methods for Kinase Drug Design

Human protein kinases are involved in several diseases which turned them into an important class for targeted therapy. To date there are almost 6,000 kinase structures in the PDB and around 70 small molecule kinase inhibitors available. Still several challenges remain related to drug promiscuity, resistance, and untapped kinase territory.

In this BioSolveIT webinar, Andrea will summarize the portfolio of methods which either use the openly available kinase data to generate new knowledge, or enable the community to engage in this data more easily. Using the TeachOpenCADD platform, she will demonstrate how to orchestrate diverse CADD tasks for individual kinases. Furthermore, Andrea’s lab developed freely available tools supporting diverse tasks: (i) KinFragLib for fragment based kinase inhibitor design, (ii) KiSSim – a KLIFS-based kinase structural similarity fingerprint, and (iii) a pipeline to assess kinase similarity from different data perspectives. All examples make use of the OpenCADD-KLIFS module to facilitate the integration of KLIFS data into kinase research workflows.

Andrea will close with further ongoing projects in structure-informed ML for kinase polypharmacology (openkinome).

Join us for an exciting talk and a vivid discussion.

Current news

"A Gaze into Chemical Space" Series
April 16, 2024 11:26 CEST
Introducing our latest series, “A Gaze into Chemical Space,” where we explore the expansive realms of combinatorial compound collections. Our aim in this exercise is to uncover similar compounds of potential and approved drugs using various methods. Typically, several synthesis steps are required to get to a compound with favorable...
Read on
Behind the Scenes of Enamine's REAL Space
April 15, 2024 16:43 CEST
Since its launch in 2018, Enamine’s REAL Space has made a significant impact in revolutionizing the landscape of compound collections. The initial version contained approximately 650 million compounds, establishing itself as one of the expansive catalogs of commercially available molecules for drug discovery. Notably, the first release rivaled even the...
Read on
category
Challenge
Martin Schwalm Emerges as Winner of Scientific Challenge Spring 2023
March 15, 2024 14:44 CET
The Scientific Challenge Spring 2023 comes to a conclusion: Martin Schwalm from the University of Frankfurt wins with his project “Identifying Binders to Hijack the Autophagy System for Targeted Protein Degradation”! The study aimed to identify binders for the LC3A protein’s hydrophobic binding site, a crucial target for drug discovery...
Read on